COVID-19, Acute Lymphoblastic Leukemia, and Down Syndrome: A Short Review and a Case Report

SARS-CoV-2 which causes COVID-19 has been a great challenge to treat and deal with; despite strict measures that had been implemented by governments and organizations, worrying rates of morbidity and mortality are still being reported. Although available data have expressed that moderate or even mil...

Descripción completa

Detalles Bibliográficos
Autores principales: Arafat, Ahmed, Sadykova, Dinara, Ziatdinov, Ayrat, Senek, Svetlana, Samoilova, Natalya, Makarova, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299389/
https://www.ncbi.nlm.nih.gov/pubmed/34326739
http://dx.doi.org/10.1159/000516442
Descripción
Sumario:SARS-CoV-2 which causes COVID-19 has been a great challenge to treat and deal with; despite strict measures that had been implemented by governments and organizations, worrying rates of morbidity and mortality are still being reported. Although available data have expressed that moderate or even mild forms of the disease are expected amongst most pediatrics cases, minimal data are available on the prognosis and the disease's complications on the immunocompromised, especially oncology patients. We report a case of relapsed precursor B-cell acute lymphoblastic leukemia of a child with Down syndrome and COVID-19 and outline the treatment regimen that we used.

Ejemplares similares